FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

324931007: Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet (clinical drug)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    465634012 Atovaquone+proguanil hydrochloride 250mg/100mg tablet en Synonym (core metadata concept) Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
    718210019 Atovaquone+proguanil hydrochloride 250mg/100mg tablet (substance) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
    1190576012 Atovaquone+proguanil hydrochloride 250mg/100mg tablet (product) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
    3489322015 Product containing atovaquone 250 mg and proguanil hydrochloride 100 mg/1 each oral tablet (clinical drug) en Fully specified name Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
    3492693013 Product containing atovaquone 250 mg and proguanil hydrochloride 100 mg/1 each oral tablet en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
    3500769010 Atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
    3566723014 Product containing only atovaquone 250 mg and proguanil hydrochloride 100 mg/1 each oral tablet en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
    3566724015 Product containing only atovaquone 250 mg and proguanil hydrochloride 100 mg/1 each oral tablet (clinical drug) en Fully specified name Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
    3676911010 Atovaquone 250 mg and proguanil 100 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3676912015 Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
    3676913013 Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3510761000005115 atovaquon + proguanilhydrochlorid tablet a 250 mg/100 mg da Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) Danish module (core metadata concept)
    3606881000005111 atovaquon + proguanilhydrochlorid tablet 250 mg/100 mg da Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) Danish module (core metadata concept)
    4725491000005118 atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet Is a Atovaquone+proguanil hydrochloride false Inferred relationship Some
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Atovaquone (substance) false Inferred relationship Some
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Proguanil hydrochloride (substance) false Inferred relationship Some
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Biguanide (substance) false Inferred relationship Some
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Some
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet Is a Proguanil hydrochloride 100 mg oral tablet false Inferred relationship Some
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Proguanil false Inferred relationship Some
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet Is a Product containing atovaquone and proguanil (medicinal product) false Inferred relationship Some
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet Has manufactured dose form Oral tablet false Inferred relationship Some
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet Is a Product manufactured as oral dose form (product) false Inferred relationship Some
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet Is a Proguanil-containing product in oral dose form false Inferred relationship Some
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet This attribute specifies the numerator unit for the presentation strength of a product. mg false Inferred relationship Some 1
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet Has presentation strength denominator value en false Inferred relationship Some 1
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) false Inferred relationship Some 1
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet This attribute specifies the numerator unit for the presentation strength of a product. mg false Inferred relationship Some 2
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet Has presentation strength denominator value en false Inferred relationship Some 2
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) false Inferred relationship Some 2
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Proguanil false Inferred relationship Some 1
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Proguanil false Inferred relationship Some 1
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet Has presentation strength numerator value 100 false Inferred relationship Some 1
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Atovaquone (substance) false Inferred relationship Some 2
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Atovaquone (substance) false Inferred relationship Some 2
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet Has presentation strength numerator value 250 false Inferred relationship Some 2
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet Is a Atovaquone- and proguanil-containing product in oral dose form false Inferred relationship Some
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet Has unit of presentation Tablet (unit of presentation) false Inferred relationship Some
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Atovaquone (substance) false Inferred relationship Some 2
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Proguanil false Inferred relationship Some 1
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet Count of base of active ingredient to false Inferred relationship Some
    atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet Is a Atovaquone and proguanil only product in oral dose form false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start